All across the country, and in fact globally, musculoskeletal (MSK) care has become difficult if not impossible for most patients to access because of the COVID-19 pandemic.
As employers plan to return to the workplace, Mercer survey reveals key considerations from employers’ experience with essential workers and COVID-19.
The FDA recently approved AstraZeneca’s Farxiga (dapagliflozin) for the treatment of heart failure with reduced ejection fraction (HFrEF) in adults with and without type 2 diabetes, marking the first time a drug in a class developed for diabetes was approved for heart failure even if diabetes is not present.
The Whole Person Care pilot program has proven to be essential for communities in California and could potentially do the same in communities around the world.
Two-year follow up of FOURIER study in 22,655 patients confirms neurocognitive safety of very low LDL-C levels using a patient self-survey tool.
Healthcare providers and payers are keeping an eye on unemployment rates across the country and in communities that have been affected the most because the rates will have an effect on the use of medical services and insurance coverage. Here is a look at some of the economies most affected.
Researchers have reported a signicant and positive relationship between the amount of virus present in a throat swab sample and the severity of COVID-19 disease.
The 3D printable mask is the first of its kind to feature a see-through front plate to help patients feel less isolated and is 100% free to download.
The Coronavirus pandemic has served as the most sobering reality and wake-up call to Americans; all starting with our diets.
FDA alerts public not to use chloroquine and hydroxychloroquine to treat COVID-19, as they are not approved to treat anything other than malaria and auto immune disorders.